Business
Israel-based Kadimastem, a biotechnology company developing cell therapies for the treatment of severe debilitating diseases announced positive interim results from the Phase 2...
Hi, what are you looking for?
Israel-based Kadimastem, a biotechnology company developing cell therapies for the treatment of severe debilitating diseases announced positive interim results from the Phase 2...
The study could lead to new treatments for a neurodegenerative condition such as ALS
Tel Aviv may be Israel’s high-tech capital, but the heart of life-sciences innovation lies in Jerusalem. Jerusalem’s life-sciences cluster includes three innovation...
Researchers from Ben-Gurion University of the Negev (BGU) have published a new study that describes a novel molecular mechanism that could lead to the...
"This patent allowance in Israel further extends the geographic reach of our intellectual property."
"Patients trapped in a dying process they find unbearable should be able to turn to their physicians and ask for medications they could consume...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the Data and Safety Monitoring Board (DSMB) met...
Video ads are likely to take Facebook by storm, with the number of companies using video advertising on the social media site rising steadily,...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced positive results from preclinical studies of its NurOwn in...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced positive final results from its phase 2a clinical trial...